Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT)
Clinical trial NCT04583592 · COMPLETED
Trial details
- NCT number
- NCT04583592
- Sponsor
- Sagent Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-09
- Primary completion
- 2021-03-31
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.